IUPAC Name: | 4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]thiomorpholine |
Description: | 4-(5-(4.4.5.5.-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)thiomorpholine can be used as FGFR inhibitors to treat cancer. |
Molecular Weight: | 306.23 |
Molecular Formula: | C15H23BN2O2S |
Canonical SMILES: | B1(OC(C(O1)(C)C)(C)C)C2=CN=C(C=C2)N3CCSCC3 |
InChI: | InChI=1S/C15H23BN2O2S/c1-14(2)15(3,4)20-16(19-14)12-5-6-13(17-11-12)18-7-9-21-10-8-18/h5-6,11H,7-10H2,1-4H3 |
InChI Key: | RTMQINQSSQUSQG-UHFFFAOYSA-N |
References: | Hudkins, R.L., et.al. WIPO WO2021138391 A1, (2021). |
Customer Support
If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?
Customer Centered
Related Functional Groups
Other Building Blocks
N-((4-Oxo-1-phenyl-4,7-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-yl)methyl)acetamide
Customers Also Viewed
Isopropyl 4-[4-[N,N-bis(2-hydroxyethyl)amino]phenyl]butyrate
Copyright © 2024 BOC Sciences. All rights reserved.
Our Products